動物感染疾病診斷市場規模、佔有率和成長分析（按感染類型、技術、動物類型、最終用戶和地區）- 產業預測，2025-2032 年

2023 年動物感染疾病診斷市場規模價值 20 億美元，預計將從 2024 年的 21.8 億美元成長到 2032 年的 43.4 億美元，預測期內（2025-2032 年）的複合年成長率為 9.0%。

動物感染疾病診斷市場對於快速且準確地識別動物感染疾病至關重要，從而改善健康結果並加強疾病控制。由於全球化、氣候變遷和農業方法演變的影響，人畜共通感染疾病呈上升趨勢，推動了市場的成長。然而，診斷成本高、發展中地區治療機會有限以及熟練專業人員短缺等挑戰可能會阻礙市場擴張。持續的研究和開發對於開發靈敏且特異性的診斷工具至關重要。儘管存在這些障礙，但透過快速和即時檢測等技術創新仍然充滿了機會。人們對通用感染疾病和「同一個健康」模式的認知不斷提高，進一步推動了這個市場的發展，鞏固了其在全球動物和公共衛生管理中的關鍵作用。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

動物感染疾病診斷市場規模（依感染類型及複合年成長率）（2025-2032）

• 市場概況
• 細菌感染疾病
• 病毒感染
• 寄生蟲感染疾病
• 其他感染疾病

動物感染疾病診斷市場規模（依技術及複合年成長率） (2025-2032)

• 市場概況
• 免疫診斷
  • 橫向流動化驗
  • ELISA 檢測
• 其他免疫診斷技術
• 分子診斷
  • 聚合酵素鏈鎖反應（PCR）檢測
  • 微陣列
• 其他分子診斷測試
• 其他獸醫診斷技術

動物感染疾病診斷市場規模（按動物類型和複合年成長率）（2025-2032）

• 市場概況
• 伴同性動物
  • 狗
  • 貓
  • 馬
• 其他寵物
• 食用動物
  • 牛
  • 豬
  • 家禽
  • 其他食用動物

動物感染疾病診斷市場規模（按最終用戶和複合年成長率） (2025-2032)

• 市場概況
• 參考實驗室
• 獸醫研究機構和診所
• 照護現場和內部測試
• 科學研究機構/大學

動物感染疾病診斷市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• IDEXX Laboratories, Inc.（US）
• Zoetis, Inc.（US）
• Thermo Fisher Scientific, Inc.（US）
• Virbac（France）
• bioMerieux SA（France）
• Heska Corporation（US）
• NEOGEN Corporation（US）
• QIAGEN NV（Netherlands）
• Randox Laboratories Ltd.（UK）
• Agrolabo S.pA.（Italy）
• Bio-Rad Laboratories（US）
• Bionote, Inc.（South Korea）
• Biogal Galed Labs（Israel）
• BioChek（Netherlands）
• Biopanda Reagents（UK）
• URIT Medical Electric Co. Ltd.（China）
• MEGACOR Diagnostik GmbH（Germany）
• Fassisi GmbH（Germany）
• Alvedia（France）
• SKYER, Inc.（South Korea）

結論和建議

Veterinary Infectious Disease Diagnostics Market size was valued at USD 2.0 billion in 2023 and is poised to grow from USD 2.18 billion in 2024 to USD 4.34 billion by 2032, growing at a CAGR of 9.0% during the forecast period (2025-2032).

The veterinary infectious disease diagnostics market is essential for the prompt and accurate identification of infectious diseases in animals, leading to enhanced health outcomes and improved disease control. Rising instances of animal infectious diseases, influenced by globalization, climate change, and evolving husbandry practices, are fueling market growth. However, challenges like high diagnostic costs, limited accessibility in developing regions, and a shortage of skilled professionals may hinder its expansion. Continuous R&D is crucial to develop sensitive and specific diagnostic tools. Despite these barriers, opportunities abound through technological innovations, such as rapid and point-of-care tests. Increased awareness of zoonotic diseases and the One Health paradigm further propels this market, solidifying its critical role in global animal and public health management.

Top-down and bottom-up approaches were used to estimate and validate the size of the Veterinary Infectious Disease Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Veterinary Infectious Disease Diagnostics Market Segments Analysis

Global Veterinary Infectious Disease Diagnostics Market is segmented by Infection Type, Technology, Animal Type, End User and Region. Based on Infection Type, the market is segmented into Bacterial Infections, Viral Infections, Parasitic Infections and Other Infections. Based on Technology, the market is segmented into Immunodiagnostics, Other immunodiagnostic technologies, Molecular Diagnostics, Other molecular diagnostic tests and Other Veterinary Diagnostic Technologies. Based on Animal Type, the market is segmented into Companion Animals, Other companion animals and Food Producing Animals. Based on End User, the market is segmented into Reference Laboratories, Veterinary Laboratories and Clinics, Point of Care / In House Testing and Research Institutes and Universities. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Veterinary Infectious Disease Diagnostics Market

The veterinary infectious disease diagnostics market is witnessing significant growth driven by heightened awareness of animal health and welfare among pet owners and livestock producers. There is a burgeoning demand for sophisticated diagnostic tools and services that facilitate the early detection and effective management of infectious diseases. The COVID-19 pandemic in 2022 underscored the critical need for monitoring animal health and establishing strong diagnostic systems to identify potential zoonotic diseases, further emphasizing the importance of investing in advanced veterinary diagnostics. This increased focus on animal welfare and disease prevention has propelled the market forward, creating a need for innovative solutions in this sector.

Restraints in the Veterinary Infectious Disease Diagnostics Market

One major constraint in the veterinary infectious disease diagnostics market is the high expense linked to advanced diagnostic technologies and services. Implementing state-of-the-art diagnostic tools often demands considerable financial investment, which can be particularly challenging for small veterinary practices or those situated in financially limited areas. This financial barrier may restrict the accessibility and application of sophisticated diagnostic techniques, ultimately restraining the overall growth of the market. As a result, the disparity in resources can lead to uneven adoption rates of these innovative technologies, impacting the efficiency of disease diagnosis and management in the veterinary field.

Market Trends of the Veterinary Infectious Disease Diagnostics Market

The Veterinary Infectious Disease Diagnostics market is increasingly influenced by the growing adoption of point-of-care testing (POCT), which has emerged as a pivotal trend. With the shift towards rapid, on-site diagnostic capabilities, veterinarians can now obtain real-time results without relying on centralized laboratories, thereby enhancing immediate decision-making and operational efficiency. This trend has accelerated since 2022, driven by advancements in portable and user-friendly POCT devices tailored for infectious disease diagnosis in animals. As the demand for timely and accurate diagnostics rises, the market is poised for significant growth, reflecting a broader commitment to improving animal health outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Veterinary Infectious Disease Diagnostics Market Size by Infection Type & CAGR (2025-2032)

• Market Overview
• Bacterial Infections
• Viral Infections
• Parasitic Infections
• Other Infections

Global Veterinary Infectious Disease Diagnostics Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Immunodiagnostics
  • Lateral flow assays
  • ELISA tests
• Other immunodiagnostic technologies
• Molecular Diagnostics
  • Polymerase chain reaction (PCR) tests
  • Microarrays
• Other molecular diagnostic tests
• Other Veterinary Diagnostic Technologies

Global Veterinary Infectious Disease Diagnostics Market Size by Animal Type & CAGR (2025-2032)

• Market Overview
• Companion Animals
  • Dogs
  • Cats
  • Horses
• Other companion animals
• Food Producing Animals
  • Cattle
  • Swine
  • Poultry
  • Other food-producing animals

Global Veterinary Infectious Disease Diagnostics Market Size by End User & CAGR (2025-2032)

• Market Overview
• Reference Laboratories
• Veterinary Laboratories and Clinics
• Point of Care / In House Testing
• Research Institutes and Universities

Global Veterinary Infectious Disease Diagnostics Market Size & CAGR (2025-2032)

• North America (Infection Type, Technology, Animal Type, End User)
  • US
  • Canada
• Europe (Infection Type, Technology, Animal Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Infection Type, Technology, Animal Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Infection Type, Technology, Animal Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Infection Type, Technology, Animal Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• IDEXX Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zoetis, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Heska Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NEOGEN Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agrolabo S.pA. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bionote, Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biogal Galed Labs (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioChek (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biopanda Reagents (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• URIT Medical Electric Co. Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MEGACOR Diagnostik GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fassisi GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alvedia (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SKYER, Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations